Management of Acutely Symptomatic Hernia (MASH)

Management of Acutely Symptomatic Hernia: An Observational Study

Acutely symptomatic abdominal wall hernia can cause many symptoms and complications. They can be associated with levels of morbidity beyond that seen in emergency laparotomy. There is limited data to guide practice in this field. This observational cohort study will explore variation in practice around assessment, repair and outcomes of hernias treated in the emergency setting.

Study Overview

Detailed Description

There are many different types of hernia, with the most common being in the groin or at the umbilicus. Hernias affect a significant proportion of the population and can vary from producing no symptoms at all, to causing a blockage to the bowel that requires urgent surgery. Hernias affect people of all ages and degrees of health, but become increasingly common with age. As our population ages and therefore becomes generally more unwell, the risks of surgery increase. Recent evidence suggests that emergency hernia repair is associated with worse outcomes than planned procedures. At present there are limited guidelines for the management of acutely symptomatic hernias and therefore practice varies between hospitals.

This cohort study will capture information on patients treated in the UK for acutely symptomatic hernia, and will provide information on variation in assessment, and technical aspects of repair. It will also capture health utility data out to 90 days post discharge from hospital.

Study Type

Observational

Enrollment (Actual)

280

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • South Yorkshire
      • Sheffield, South Yorkshire, United Kingdom, S5 7AU
        • Sheffield Teaching Hospitals NHS Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Potential participants will be identified from attendance at UK hospitals which provide emergency surgical services.

Description

Inclusion Criteria:

  • Patients aged 18 years and over
  • Patients admitted directly to the emergency surgery service (via A+E or GP)
  • Patients referred to the emergency surgical team by another inpatient specialty
  • Patients with a diagnosis of an acutely symptomatic hernia made by a specialist surgical trainee (ST3+) or Consultant Surgeon
  • Willing to take part in the study

Exclusion Criteria:

  • Patients under 18 years of age
  • Pregnant women
  • Patients with a symptomatic parastomal, hiatal or diaphragmatic hernia
  • Patients with a traumatic hernia
  • Unable to consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with acutely symptomatic abdominal wall hernia
Patients presenting to emergency surgical services with acutely symptomatic abdominal wall hernia (excluding parastomal).
Emergency repair of hernia using method selected by treating surgeon.
Treatment of hernia without resort to surgery
Other Names:
  • Non-operative management

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
In hospital morbidity
Time Frame: up to 28 days after surgery
As defined using the comprehensive complication index
up to 28 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: Measured at baseline, 30 days post discharge, and 90 days post recruitment
Death occuring (binary)
Measured at baseline, 30 days post discharge, and 90 days post recruitment
Hospital length of stay
Time Frame: Within 30 days of recruitment to study
Time from admission to discharge measured in days
Within 30 days of recruitment to study
Unplanned readmission within 30 days
Time Frame: Up to 30 days of recruitment
Unplanned readmission to hospital for any reason following treatment of hernia
Up to 30 days of recruitment
Change in health utility
Time Frame: Measured at baseline, 30 days post discharge and 90-days post recruitment
Measured using EQ-5D-5L questionnaire
Measured at baseline, 30 days post discharge and 90-days post recruitment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthew J Lee, MRCS PhD, Sheffield Teaching Hospitals NHS Foundation Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 3, 2020

Primary Completion (Actual)

November 30, 2020

Study Completion (Anticipated)

March 24, 2021

Study Registration Dates

First Submitted

September 9, 2019

First Submitted That Met QC Criteria

December 10, 2019

First Posted (Actual)

December 13, 2019

Study Record Updates

Last Update Posted (Actual)

January 6, 2021

Last Update Submitted That Met QC Criteria

January 5, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • STH20908

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergencies

Clinical Trials on Emergency Hernia Repair

3
Subscribe